These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34100557)

  • 1. Histone demethylase PHF8 promotes cell growth and metastasis of non-small-cell lung cancer through activating Wnt/β-catenin signaling pathway.
    Hu Y; Mu H; Yang Y
    Histol Histopathol; 2021 Aug; 36(8):869-877. PubMed ID: 34100557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
    Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
    Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histone demethylase PHF8 is an oncogenic protein in human non-small cell lung cancer.
    Shen Y; Pan X; Zhao H
    Biochem Biophys Res Commun; 2014 Aug; 451(1):119-25. PubMed ID: 25065740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
    Zhang Z; Yang Y; Zhang X
    Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
    Zhao M; Ma W; Ma C
    Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
    Yang S; Liu Y; Li MY; Ng CSH; Yang SL; Wang S; Zou C; Dong Y; Du J; Long X; Liu LZ; Wan IYP; Mok T; Underwood MJ; Chen GG
    Mol Cancer; 2017 Jul; 16(1):124. PubMed ID: 28716029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R; Zhang FH; Shen N
    Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
    Zhang Y; Zhang Q; Chen H; Wang C
    Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and potential molecular mechanism of TOP2A in metastasis of non-small cell lung cancer.
    Wu J; Li W; Zhang X; Shi F; Jia Q; Wang Y; Shi Y; Wu S; Wang X
    Sci Rep; 2024 May; 14(1):12228. PubMed ID: 38806610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
    Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
    Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBX8 Promotes Epithelial-mesenchymal Transition, Migration, and Invasion of Lung Cancer through Wnt/β-catenin Signaling Pathway.
    Cai X; Lv Y; Pan J; Cao Z; Zhang J; Li Y; Zheng H
    Curr Protein Pept Sci; 2024; 25(5):386-393. PubMed ID: 38265409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
    Qi G; Li L
    Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
    Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
    Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.
    Wei Y; Ouyang GL; Yao WX; Zhu YJ; Li X; Huang LX; Yang XW; Jiang WJ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3847-3856. PubMed ID: 31115012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-489-3p promotes malignant progression of non-small cell lung cancer through the inactivation of Wnt/β-catenin signaling pathway via regulating USP48.
    Zhang P; Li L; Wang B; Ran X; Yang S; Luo Y; Li Y; Wang Z; Liu Y; Zhu B
    Respir Res; 2022 Apr; 23(1):93. PubMed ID: 35413838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRDX1 stimulates non-small-cell lung carcinoma to proliferate via the Wnt/β-Catenin signaling.
    Song C; Xiong G; Yang S; Wei X; Ye X; Huang W; Zhang R
    Panminerva Med; 2023 Mar; 65(1):37-42. PubMed ID: 32881473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone demethylase PHF8 promotes epithelial to mesenchymal transition and breast tumorigenesis.
    Shao P; Liu Q; Maina PK; Cui J; Bair TB; Li T; Umesalma S; Zhang W; Qi HH
    Nucleic Acids Res; 2017 Feb; 45(4):1687-1702. PubMed ID: 27899639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00514 facilitates cell proliferation, migration, invasion, and epithelial-mesenchymal transition in non-small cell lung cancer by acting on the Wnt/β-catenin signaling pathway.
    Zhu Y; Wu H; Yang X; Xiong Z; Zhao T; Gan X
    Bioengineered; 2022 May; 13(5):13654-13666. PubMed ID: 35653786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.